[The use of ketamine in patients with liver damage (author's transl)].
Continuous ketamine drip anaesthesia was used in 151 patients with liver disease. The anaesthetic management is described and changes in serum enzymes and bilirubin are reported. Our results indicate that ketamine does not impair hepatacellular function.
D000758:Anesthesia; D001794:Blood Pressure / Q000187:drug effects; D004329:Droperidol / Q000494:pharmacology; D005234:Fatty Liver / Q000097:blood; D006339:Heart Rate / Q000187:drug effects; D006505:Hepatitis / Q000097:blood; D006801:Humans; D007565:Jaundice; D007649:Ketamine / Q000494:pharmacology; D008103:Liver Cirrhosis / Q000097:blood; D008107:Liver Diseases / Q000097:blood
D007649:Ketamine; D004329:Droperidol
Anwendung von Ketamin bei lebergeschädigten Patienten